Mary Spellman
Overview
Mary Spellman received an average of $982K in total compensation, including $263K in salary, at VYNE Therapeutics between 2017 and 2018.
Source: SEC filing on May 10, 2019.
Related executives
We found seven more executives who work or worked at VYNE Therapeutics.
David Domzalski
VYNE Therapeutics
Chief Executive Officer
Mutya Harsch
VYNE Therapeutics
Chief Legal Officer
Iain Stuart
VYNE Therapeutics
Chief Scientific Officer
Steven Basta
VYNE Therapeutics
Chief Executive Officer
Andrew Saik
VYNE Therapeutics
Chief Financial Officer
Kristine Ball
VYNE Therapeutics
Chief Financial Officer
Paul Kwon
VYNE Therapeutics